Fexofenadine/pseudoephedrine

Fexofenadine/pseudoephedrine, sold under the brand name Allegra-D among others, is a fixed-dose combination medication used for the treatment of nasal congestion and other symptoms of allergies[4] and the common cold.[2] It contains fexofenadine, as the hydrochloride, an antihistamine; and pseudoephedrine, as the hydrochloride, a nasal decongestant.[2]

Fexofenadine/pseudoephedrine
Combination of
FexofenadineAntihistamine
PseudoephedrineNasal decongestant
Clinical data
Trade namesAllegra-D
MedlinePlusa601053
License data
Pregnancy
category
  • AU: B2
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

In 2021, it was the 279th most commonly prescribed medication in the United States, with more than 800,000 prescriptions.[5][6]

References
  1. "Allegra-D Product information". Health Canada. 25 April 2012. Retrieved 2 June 2022.
  2. "Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 3 December 2020. Retrieved 2 June 2022.
  3. "Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 30 August 2021. Retrieved 2 June 2022.
  4. Mansfield LE (May 2006). "Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis". Expert Opinion on Pharmacotherapy. 7 (7): 941–51. doi:10.1517/14656566.7.7.941. PMID 16634716. S2CID 23165002.
  5. "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
  6. "Fexofenadine; Pseudoephedrine - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.